Russia

 

Interview: Julian Andriesz, CEO, Verita Healthcare

The massive latent demand to live longer is being tapped by a new generation of health care providers. British entrepreneur Julian Andriesz, 53, made a first fortune building business in SE Asia and got into prevention after watching his mother die of ovarian cancer, diagnosed late. He says his intention is to help his clients, whether they are healthy, have cancer or auto-immune diseases, to live longer, better lives. Verita has a chain of 10 clinics, believes its digital health disease prevention and management platform is about to become the largest in the world and owns IP, and research and manufacturing in Europe, Asia and Australia.
September 12, 2019

Bridgepoint “exploring” €2bn sale/IPO of Diaverum

As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.
August 1, 2019

MedMa invests in radiotherapy

The Russian investor behind Citilab, Nefroline and Genome is set to invest RUB350m ($5.5m) in a radiotherapy centre in western Russia.
July 17, 2019

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 
July 3, 2019

Medsi triples public work, targets IPO

Russian private healthcare operator Medsi tripled its work with the public payor in Q1 2018, growing revenues by half and nearly doubling margins. We talk owner Sistema about expanding Medsi outside of Moscow, and its IPO plans.
June 20, 2019

Is the perception of risk in Russia too dramatic?

In the last ten years, Russia has lept from 120th on the World Bank’s ‘ease of doing business’ scale to 31st, beating China, India and Turkey. Are worries about risk now over-inflated? Panellists at HBI 2019’s session on Russia and the CIS discuss.
April 25, 2019

New Russian law opens domiciliary care market

A new taxation law being piloted in and around Moscow City has created a market for domiciliary care services offered by self-employed professionals. We speak to Russian nursing home provider Senior Group, which is launching a new private pay service off the back of this change.
April 23, 2019

Russian IVF group’s international plans points to tough home market

The general director of one of Russia's largest IVF groups, Ava-Peter, told HBI 2019 delegates that the company has plans to enter the Uzbekistani market. The announcement points to just how tough the situation has become for private IVF operators in Russia in recent years.
April 16, 2019
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us